| October 20, 2011 |
| Herceptin and Chemotherapy Treatment Combo Increases Survival Rates |
 |
In this NBC Nightly News video, watch UCLA Jonsson Comprehensive Cancer Center researcher Dr. Dennis Slamon discuss a new study that reports that treating women with a combination of chemotherapy and the molecularly targeted drug Herceptin can significantly increase survival in patients with a specific genetic mutation that results in very aggressive disease. |
| September 30, 2011 |
| UCLA Researcher Works to Fight Cancer |
 |
In this profile from the Brentwood Patch, UCLA's Jonsson Comprehensive Cancer Center researcher Heather Christofk takes a tour of the center's facilities and discusses her work on the front lines in the fight against cancer. |
| August 5, 2011 |
| Bladder Cancer Patients Not Receiving Recommended Care, Study Says |
 |
Watch UCLA researcher Dr. Karim Chamie talk about a Jonsson Cancer Center study that showed nearly all doctors treating bladder cancer patients are not following the recommended care guidelines, which are designed to prevent recurrence of the cancer. |
| Nov 22, 2010 |
| Herceptin Gives Breast Cancer Survivor Second Chance at Life |
 |
Cancer survivor Sue Service shares her story of battling HER2+ breast cancer and the benefits of the targeted treatment Herceptin, developed by Jonsson Comprehensive Cancer Center's Dennis Slamon and his "dream team" of cancer researchers. |
| August 26, 2010 |
| New Hope for Melanoma Patients |
 |
Watch UCLA's Dr. Antoni Ribas discuss an experimental new drug that is offering new hope to patients in the final stages of melanoma skin cancer. From CBS News. |
| July 20, 2010 |
| Starving Brain Cancer |
 |
Dr. Paul Mischel, a professor of pathology and laboratory medicine at UCLA's Jonsson Comprehensive Cancer Center, discusses a new class of targeted drugs called EGFR inhibitors that teach the brain new ways to kill cancer cells by "starving" them to death. From Ivanhoe News. |
| March 2010 |
| Age Likely a Factor in Colon Cancer Chemotherapy |
 |
Dr. Katherine Kahn at UCLA's Jonsson Comprehensive Cancer Center discusses how special chemotherapy treatments help patients with advanced colon cancer beat the disease, but older patients are less likely to receive the treatment because of concerns about adverse side effects. |
| July 2009 |
| Dining Out to End Cancer on "Good Day LA" |
| Mar Yvette, writer and senior editor of Citysearch, has food from restaurants involved in a fantastic fundraising campaign called "Dining Out To End Cancer." |
| July 2009 |
| Volunteers Sought for "Chemo Brain" Study |
 |
Researchers at UCLA’s Jonsson Comprehensive Cancer Center are seeking volunteers recently treated for breast cancer who may be experiencing cognitive difficulties, a condition often referred to as “chemo brain.” |
| June 2009 |
| Robotic Surgery Helps Prostate Cancer Patient |
 |
Barry Broughton and his physician, Dr. Robert Reiter, a urologist and researcher at UCLA's Jonsson Cancer Center, talked about his options for treatment, including radiation and different types of surgery. |
| November 2008 |
| Herceptin/Avastin Combo Saves Stephanie Grimes |
 |
Stephanie Grimes had an extremely aggressive form of breast cancer and was given only two months to live. But two years later she's still going strong thanks to a clinical trial at UCLA's Jonsson Cancer Center. |
| November 2008 |
| Dr. Dennis Slamon Discusses the Development of Herceptin |
 |
Herception--a targeted therapy breast cancer drug developed at UCLA's Jonsson Comprehensive Cancer Center--saved the life of Louise Cooper, who is still going strong 10 years after receiving a cancer diagnosis. |
| June 2008 |
| New Vaccine Helps Victims of Brain Cancer |
 |
Doctors and UCLA's Jonsson Comprehensive Cancer Center were able to save the life of Kevin Carlberg, who at the age of 25 was diagnosed with glioblastoma. |
Last updated: 7/27/2012 2:04:09 PM